Comparison of Interleukin ‑33 Serum Levels in Asthmatic Patients with a Control Group and Relation with the Severity of the Disease

Conclusions:IL ‑33 is suggested as a new inflammatory marker of severe and refractory asthma. Therefore, it may be a unique therapeutic target in these patients.Keywords:Asthma, interleukin ‑33, severity
Source: International Journal of Preventive Medicine - Category: International Medicine & Public Health Source Type: research